Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sfil.in | |
Market Cap | 1,298.14 Cr. | |
Enterprise Value(EV) | 1,371.65 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.28 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 49.20 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.30 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 2.95 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.68 | Calculated using Price: 13.81 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 94.00 Cr. | 940,000,000 Shares |
FaceValue | 1 | |
About Syncom Formulations (India) Ltd. | ||
Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956. Further the status of company was changed to public limited company and thereby name of company changed to Syncom Formulations (India) Limited and a fresh certificate of change of name obtained on July 9, 1992. |
1 Day |
|
-2.14% |
1 Week |
|
+8.27% |
1 Month |
|
+15.55% |
3 Month |
|
-10.71% |
6 Month |
|
+66.67% |
1 Year |
|
+127.27% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
7 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 6.45 | 10.19 | 9.99 | 9.91 | 9.32 | 11.83 | 8.48 | |
Return on Capital Employed (%) | 10 | 15.29 | 15.55 | 14.72 | 13.28 | 13.72 | 9.68 | |
Return on Assets (%) | 4.54 | 6.95 | 6.82 | 6.41 | 5.78 | 8.04 | 5.85 |
Particulars | 8 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 88 | 95 | 100 | 109 | 117 | 222 | 256 | 270 | |
Non Curr. Liab. | 8 | 7 | 6 | 6 | 8 | 8 | 9 | 9 | |
Curr. Liab. | 29 | 42 | 37 | 66 | 59 | 78 | 113 | 124 | |
Minority Int. | |||||||||
Equity & Liab. | 124 | 144 | 143 | 181 | 184 | 308 | 378 | 404 | |
Non Curr. Assets | 63 | 66 | 59 | 89 | 97 | 168 | 196 | 213 | |
Curr. Assets | 62 | 78 | 84 | 92 | 87 | 140 | 182 | 191 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 124 | 144 | 143 | 181 | 184 | 308 | 378 | 404 |
Particulars | 8 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 115 | 151 | 173 | 184 | 185 | 220 | 224 | 250 | |
Other Income | 1 | 1 | 2 | 3 | 3 | 12 | 15 | 17 | |
Total Income | 116 | 152 | 175 | 187 | 188 | 232 | 239 | 267 | |
Total Expenditure | -104 | -135 | -155 | -167 | -168 | -200 | -204 | -224 | |
PBIDT | 12 | 17 | 20 | 19 | 19 | 32 | 35 | 43 | |
Interest | -1 | 0 | 0 | 0 | 0 | -2 | -3 | -5 | |
Depreciation | -3 | -3 | -3 | -3 | -3 | -4 | -5 | -5 | |
Taxation | -3 | -5 | -6 | -6 | -5 | -6 | -7 | -8 | |
Exceptional Items | -1 | 0 | 0 | 0 | 0 | 0 | |||
PAT | 6 | 9 | 10 | 10 | 11 | 20 | 20 | 26 | |
Minority Interest | |||||||||
Share Associate | |||||||||
Other Related Items | |||||||||
Consolidated Net Profit | 6 | 9 | 10 | 10 | 11 | 20 | 20 | 26 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 7 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 6 | 7 | 0 | 24 | 14 | 16 | 11 | |
Cash Fr. Inv. | 0 | -4 | 1 | -23 | -18 | -27 | -45 | |
Cash Fr. Finan. | -6 | -1 | 1 | -2 | 5 | 8 | 35 | |
Net Change | -1 | 2 | 2 | -1 | 1 | -2 | 1 | |
Cash & Cash Eqvt | 4 | 5 | 7 | 6 | 7 | 0 | 1 |
Fri, 12 Apr 2024
Disclosure under SEBI Takeover Regulations ᅡᅠKedarmal Shankarlal Bankdaᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Mon, 08 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Syncom Formulations (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Fri, 29 Mar 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent SYNCOM FORMULATIONS (INDIA) LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Wed, 24 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Closing Above Previous High |
Closing Above Previous High For 3 Days |